Genlabs KPV (Lysine–Proline–Valine) is a naturally occurring tripeptide fragment of the alpha-Melanocyte-Stimulating Hormone (α-MSH), known for its strong anti-inflammatory and immunomodulatory properties. It has been widely studied in research focused on gut health, skin conditions, and systemic inflammation.

By reducing harmful inflammatory markers like TNF-α and IL-6 without broadly suppressing the immune system, KPV offers a targeted approach to studying chronic inflammation. Its excellent safety profile and minimal side effects make it a valuable compound in preclinical and laboratory research environments.

How It Works?

KPV works by blocking key pro-inflammatory molecules in the body, such as TNF-α, IL-6, and NF-κB, which are responsible for causing redness, swelling, and pain during inflammation.

Unlike many traditional anti-inflammatory agents, KPV does not suppress the immune system as a whole—instead, it selectively calms overactive immune responses. This makes it especially useful in research focused on conditions like inflammatory bowel disease (IBD), skin inflammation, and autoimmune-related tissue damage.

Dosage :

Reconstitution: Mix with 1–2 mL of bacteriostatic water

Typical Dose:

250–500 mcg per day

Route of Administration:

Commonly administered via subcutaneous.

Duration :

Usually 2–4 weeks.

Benefits :

• Reduces Inflammation
• Supports Gut Health
• Balances the Immune System
• Improves Skin Health
• Aids in Tissue Repair

Side Effects :

Some potential side effects observed in laboratory settings include:

• Mild redness or irritation at the injection site
• Temporary fatigue or lethargy in some test subjects
• Over-suppression of inflammation (if used in excessive amounts)

Conclusion :

Genlabs KPV 10mg is a powerful research peptide known for its targeted anti-inflammatory and immune-modulating effects. Its ability to reduce inflammation without suppressing the entire immune system makes it a valuable tool in studies involving gut health, skin conditions, and chronic inflammation.